Dr Gabriele Fontane > Oppenhoff > Frankfurt, Germany > Lawyer Profile

Oppenhoff
BOCKENHEIMER LANDSTRASSE 2-4
60306 FRANKFURT AM MAIN
Germany

Work Department

Corporate Law, Mergers and Acquisition, Private Equity

Position

Gabriele Fontane joined Oppenhoff in 2018. Gabriele Fontane has been advising M&A and private equity transactions and on corporate law since the mid-1990ies, with a focus on MBO/LBO transactions. She is also specialized in acquisition finance and management participation programs. Among Gabriele Fontane’s clients are financial investors/private equity funds, corporates, MBO managers and entrepreneurs who consider selling their business.

Career

Gabriele Fontane joined Oppenhoff in 2018. Before she was a founding partner of Otto Mittag Fontane, a law firm specialized in advising on M&A and private equity transactions, which was set up in 2009 in the course of a spin-off of Thümmel, Schütze & Partner’s Frankfurt office. Gabriele Fontane practiced at Thümmel, Schütze & Partner for 14 years, including 11 years as a partner of the firm. Since 2006 she is a lecturer on private equity at Frankfurt School of Finance & Management and recently became a member of its M&A board.

Languages

German, English

Memberships

Since 2006 she is a lecturer on private equity at Frankfurt School of Finance & Management and recently became a member of its M&A board.

Education

She studied law at Johann Wolfgang von Goethe University in Frankfurt am Main and started her career in 1993 as a foreign associate at Curtis, Mallet-Prevost, Colt & Mosle in New York.

Lawyer Rankings

Deutschland > Branchenfokus > Gesundheit

Oppenhoff konnte 2020 die Themen medizinisches Cannabis und regulatorische Beratung zu Covid-19 erfolgreich besetzen, wobei schwerpunktmäßig zu Marktzugangs- und Erstattungsfragen beraten wurde. Im Pharmasektor prägten M&A-Transaktionen und streitige Verfahren das Mandatsaufkommen. Zunehmend ist die Kanzlei auch in der Venture Capital-Szene aktiv, beispielsweise für Healthcare-Start-ups. Das Thema Digitalisierung kann ebenfalls hausintern abgedeckt werden. Gabriele Fontane in Frankfurt leitet das Team.

Germany > Industry focus > Healthcare and life sciences

In 2020, Oppenhoff advised on medical cannabis and regulatory matters in the context of Covid-19, market access and reimbursement issues were a particular focus. In the pharmaceutical space, the key areas are M&A transactions and litigation. The firm also increasingly handles venture capital mandates, for example for healthcare startups, and also covers digitisation matters. Gabriele Fontane in Frankfurt leads the team.